HEART FAILURE: Mitochondrial dysfunction and oxidative stress in CHF

    loading  Checking for direct PDF access through Ovid

Abstract

The results of the Q-SYMBIO trial showing a reduction in mortality in patients with heart failure treated with coenzyme Q10 have substantial limitations. Nevertheless, they highlight the need to identify effective new therapies targeted at mitochondrial dysfunction and oxidative stress in heart failure.

Related Topics

    loading  Loading Related Articles